ClinConnect ClinConnect Logo
Search / Trial NCT04572321

Youth Depression and Suicide Research Network

Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Sep 30, 2020

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Depression Suicide Suicidal Ideation Suicide Attempt Teen Child Depressive Episode Depression In Teens

ClinConnect Summary

The Youth Depression and Suicide Research Network is a clinical trial aimed at understanding and improving how we address depression and suicidal thoughts among young people in Texas. The study involves several healthcare sites across the state, working together to gather information and create a registry of participants. This research will help identify effective treatments and support systems for youth struggling with these issues.

To be eligible to participate, individuals must be between 8 and 20 years old and show signs of depression or suicidal thoughts. Participants should be willing to provide consent (or have a parent/guardian do so if they're younger) and must be able to communicate in English or Spanish. Those who join the study can expect to complete assessments and surveys about their mental health, and they will be supported throughout the process by healthcare professionals. It’s important to know that individuals with certain serious medical or psychological conditions may not be able to participate for their safety.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Be 8 to 20 years of age;
  • 2. Have a positive screen for depression (e.g., based on PHQ-2 (score ≥3) and/or PHQ-A of 10 or greater, OR positive for suicidal ideation or behavior (e.g., based on CHRT-SR or PHQ-A item 9); OR be in treatment for depression;
  • 3. Be willing to provide consent/assent (parents/LAR/guardian or young adult participant, aged 18-20, must be willing to provide consent; youth, aged 8-17, must be willing to provide assent);
  • 4. Be able to read, write and speak English or Spanish sufficiently to understand the study procedures and provide written informed consent to participate in the study;
  • 5. Be willing to dedicate appropriate time to complete scheduled study assessments and measures (both parent/LAR/guardian and youth).
  • 6. Be able to provide a reliable means of contact.
  • Exclusion Criteria:
  • 1. Have an acute medical or psychological condition(s) that that would, in the judgment of the study medical clinician, make participation difficult or unsafe;
  • 2. Have an acute medical or psychological condition(s) that would result in an inability to accurately complete study requirements (e.g., neurological conditions or significant neurodevelopmental concerns);
  • 3. Have active psychotic symptoms resulting in altered mental status and inability to provide assent or requiring immediate attention and/or higher level of intervention;
  • 4. Have a parent/LAR/guardian who is deemed cognitively unable to provide consent (if youth participant, aged 8-17).

About University Of Texas Southwestern Medical Center

The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.

Locations

Dallas, Texas, United States

Patients applied

0 patients applied

Trial Officials

Madhukar Trivedi, MD

Principal Investigator

University of Texas Southwestern Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials